(starting April 1, 2026) The German Research Foundation (DFG) provides funding to Hannover Medical School (MHH) to maintain a Research Training Group (RTG) (coordinator: Dirk Schlüter, Hannover). The central aim [...] and therapy, they remain among the leading causes of death worldwide. The increasing antibiotic resistance of bacteria and the lack of effective antiviral drugs represent a major problem. In particular [...] expertise synergistically complements each other. The 10 PhD projects of Hannover Medical School (MHH), TWINCORE in Hanover and the Helmholtz-Centre for Infection Research (HZI) will jointly apply innovative
potential of innate lymphoid cells in the immune network of liver cancer to overcome resistance to immunotherapy’; https://www.mhh.de/presse-news/mit-zellen-des-angeborenen-immunsystems-leberkrebs-bekaempfen ) [...] Junior Research Group: https://www.mhh.de/presse-news/mit-zellen-des-angeborenen-immunsystems-leberkrebs-bekaempfen Else-Kröner-Memorial Scholarship: https://www.mhh.de/presse-news/immuntherapie-gegen [...] interaction of innate lymphoid cells and microbiota in subtypes of cholangiocarcinoma’; https://www.mhh.de/presse-news/immuntherapie-gegen-gallengangskrebs-wirksamer-machen ) Dr Heinrich is group leader
iGUARD project is a cooperation between the MHH Institute for Experimental Haematology (Professor Dr. Dr. Axel Schambach, Philippe Vollmer Barbosa), the MHH Clinic for Haematology, Haemostaseology, Oncology [...] Axel Schambach, head of the Institute for Experimental Haematology at the Hannover Medical School (MHH), is developing RNA-based drugs to combat viral diseases in cooperation with the Fraunhofer Institute [...] databases. These are indispensable for the virus and are therefore unlikely to change, so that no resistance can develop. Such a search normally takes months or years. Thanks to a self-constructed development
10.06.2022 Clinical researchers at Hannover Medical School (MHH) have succeeded for the first time worldwide in stopping the usually fatal course of the disease in severe pulmonary hypertension thanks [...] Professor Hansmann and Professor Dr Ralf Hass from the Department of Gynaecology and Obstretics at MHH. A very large team of scientists, researchers and doctors helped to implement this "individual healing [...] Medical School in Boston, but also through in vivo experiments conducted by his research group at MHH - and ultimately through the request of the parents. Professor Hass' research group from the Department
l scientific networks and research associations (e.g. the German Center for Lung Research (DZL), RESIST Cluster of Excellence , pedCAPNETZ and TRAIN ), we pursue an active program in basic and clinical
iGUARD project is a collaboration between the MHH Institute of Experimental Haematology (Professor Dr Dr Axel Schambach, Philippe Vollmer Barbosa), the MHH Clinic for Haematology, Haemostaseology, Oncology [...] Dr Dr Axel Schambach, Head of the Institute of Experimental Haematology at Hannover Medical School (MHH), and Prof. Dr Armin Braun, Head of Preclinical Pharmacology and Toxicology at the Fraunhofer Institute [...] regions. These are essential for the virus and are therefore unlikely to change, meaning that resistance cannot develop. Such a search normally takes months or years. Thanks to a self-constructed development
this way. The iGUARD project is a cooperation between the MHH Institute for Experimental Haematology (Professor Dr. Dr. Axel Schambach), the MHH Clinic for Haematology, Haemostaseology, Oncology and Stem [...] Axel Schambach, head of the Institute for Experimental Haematology at the Hannover Medical School (MHH), in cooperation with the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, aims [...] conserved regions that are indispensable for the virus and are therefore unlikely to change, so that no resistance can develop," the scientist notes. Such a search usually takes several months, sometimes even years
Medical School (MHH), the German Center for Infection Research (DZIF), the NAKO Health Study and TWINCORE. He was also active in the RESIST Cluster of Excellence , which is headed by the MHH. Dedicated e
ung MHH plus awarded the prizes on Monday, 13 June 2022, at the Hannover Medical School (MHH). Lower Saxony's Minister for Science and Culture Björn Thümler presented the awards together with MHH President [...] practice," emphasises MHH President Prof. Dr. Michael Manns. "And PD Dr Anna Saborowski's research shows how significant personalised tumour therapy is for overcoming therapy resistance." Outstanding researcher [...] to Dr Anna Saborowski from the Department of Gastroenterology, Hepatology and Endocrinology at the MHH. As a Clinical Scientist at the interface between patient care and basic research, she significantly
https://www.dzif.de/en/infections-immunocompromised-host RESIST (Resolving Infection Susceptibility) Excellence Cluster “RESIST” https://www.resist-cluster.de/en/ National Institutes of Health (NIH) htt [...] Assistant Professor at NYU before joining the Institute of Virology at the Hannover Medical School (MHH) in 2021 as a DZIF Associate Professor. Alumni of the Group - Selected articles, reviews, and book